海爾智家(06690.HK)斥6.4億美元購開利(CARR.US)旗下商用製冷業務
海爾智家(06690.HK)公布,擬通過全資附屬以約6.4億美元(約45.59億人民幣)現金收購開利集團(CARR.US)旗下商用製冷業務Carrier Refrigeration Benelux B.V.的100%股權及相關資產。
目標業務在食品零售行業中提供全球領先的端到端商用製冷解決方案,其主要產品包含在食品零售行業(如商超)使用的製冷櫃、製冷機組,以及在冷庫使用的CO2製冷機組及配套服務。
公司指出,基於公司在家庭製冷領域的全球引領地位,公司擬從家庭製冷拓展到零售製冷、冷庫製冷等商用製冷領域,未來擬拓展到其他商用冷鏈場景,創造公司新的增長點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.